Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 16, Issue 4, Pages 1094-1101Publisher
WILEY
DOI: 10.1111/ajt.13582
Keywords
editorial; personal viewpoint; ethics and public policy Discipline
Categories
Funding
- NIDDK NIH HHS [R01 DK088791] Funding Source: Medline
Ask authors/readers for more resources
The development of new immunosuppressive drugs has slowed markedly over the past several years, and the outlook that improved therapy will be available to the next generation of transplant recipients is bleak. In this viewpoint, the authors outline some of important barriers to new drug development and suggest specific steps that the transplant community can take to overcome them. This viewpoint from a diverse group of transplant professionals outlines some of the important barriers to new immunosuppressive drug development and suggests specifi c steps that the transplant community can take to overcome them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available